Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Vaxart Inc. (VXRT)

6.81   -0.19 (-2.71%) 09-29 10:34
Open: 6.88 Pre. Close: 7
High: 6.97 Low: 6.71
Volume: 2,267,787 Market Cap: 789M
Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines. The company is headquartered in South San Francisco, California and currently employs 28 full-time employees. The firm has three product candidates in clinical development that address viral infections that have limited therapeutic options. Its products include vapendavir, an oral treatment for human rhinovirus (HRV) upper respiratory infections in moderate-to-severe asthmatics in Phase IIb SPIRITUS trial; BTA585, an oral fusion (F) protein inhibitor in Phase II development for the treatment and prevention of respiratory syncytial virus (RSV) infections, and BTA074, a topical antiviral treatment in Phase II development for condyloma caused by human papillomavirus Types 6 and 11. The company has preclinical RSV non-fusion inhibitor program. The company has focused its research and drug development capabilities on discovering and developing small molecule compounds that can prevent or treat infectious diseases.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 7.632 - 7.674 7.674 - 7.708
Low: 6.69 - 6.745 6.745 - 6.79
Close: 6.917 - 7.001 7.001 - 7.068

Technical analysis

as of: 2020-09-29 10:17:31 AM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 8.82     One year: 11.01
Support: Support1: 4.51    Support2: 3.75
Resistance: Resistance1: 7.55    Resistance2: 9.43
Pivot: 7.07
Moving Average: MA(5): 7.08     MA(20): 6.59
MA(100): 6.83     MA(250): 3.38
MACD: MACD(12,26): -0.07     Signal(9): -0.19
Stochastic oscillator: %K(14,3): 50.83     %D(3): 51.66
RSI: RSI(14): 47.42
52-week: High: 17.49  Low: 0.27  Change(%): 1817.8
Average Vol(K): 3-Month: 2791879  10-Days: 2847611

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
VXRT has closed above bottom band by 46.7%. Bollinger Bands are 8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 29 Sep 2020
Vaxart Inc. (VXRT) market price of $7.00 offers the impression of an exciting value play - The InvestChronicle

Mon, 28 Sep 2020
Riding the Trend or Protecting Profits | Vaxart Inc. (VXRT) - The News Heater

Sun, 27 Sep 2020
ROSEN, A TOP RANKED FIRM, Reminds Vaxart, Inc. Investors of Important October 23 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – VXRT - GlobeNewswire

Fri, 25 Sep 2020
VAXART INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Vaxart, Inc. - VXRT - Yahoo Finance

Fri, 25 Sep 2020
Do Options Traders Know Something About Vaxart (VXRT) Stock We Don't? - Yahoo Finance

Tue, 22 Sep 2020
Vaxart Inc. (NASDAQ:VXRT) Receives FDA Clearance For Oral COVID-19 Vaccine To Commence Phase 1 Trials - BP Journal

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 109
Shares Float (M) 108
% Held by Insiders 1.21
% Held by Institutions 36.23
Shares Short (K) 13,430
Shares Short P. Month (K) 6,580

Stock Financials

EPS -0.440
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 0.420
Profit Margin -281.50
Operating Margin -186.49
Return on Assets (ttm) -17.9
Return on Equity (ttm) -78.3
Qtrly Rev. Growth 515.3
Gross Profit (p.s.) -0.043
Sales Per Share 0.071
EBITDA (p.s.) -0.109
Qtrly Earnings Growth
Operating Cash Flow (M) -12
Levered Free Cash Flow (M) 0

Stock Valuations

PE Ratio -15.69
PEG Ratio
Price to Book value 16.44
Price to Sales 96.78
Price to Cash Flow -63.62

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date 2012-11-08
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.